A new clinical trial sponsored by Necmettin Erbakan University is set to explore the combined effectiveness of laser therapy and pelvic floor muscle training (PFMT) for managing stress urinary incontinence (SUI). The trial, listed as not yet recruiting, is a noteworthy step for patients and clinical professionals dealing with urinary incontinence.
What changed?
The trial, titled “Laser Therapy and Pelvic Floor Muscle Training for Stress Urinary Incontinence,” explores a dual approach to treating SUI. By integrating laser therapy with behavioral pelvic floor muscle exercises, researchers aim to determine the feasibility and effectiveness of the combined therapy for individuals struggling with urinary incontinence. This study has yet to begin recruiting as of January 11, 2026.
Given that SUI affects millions of individuals worldwide, this research holds potential to optimize non-invasive treatment strategies. Necmettin Erbakan University, known for its dedication to clinical innovation, is spearheading the trial to develop evidence-based methods to treat this condition effectively.
What are the interventions?
The trial will test the following interventions across three participant groups:
- PFMT+Laser Therapy Group: This group will receive both behavioral pelvic floor muscle training and laser-based therapy.
- Placebo Laser Group: Participants in this group will engage in pelvic floor muscle exercises while receiving a placebo laser intervention.
- PFMT-Only Group: In this group, participants will focus exclusively on pelvic floor muscle exercises.
Through this multifaceted design, researchers will examine the efficacy and compatibility of laser therapy when combined with established pelvic floor exercise programs.
Who might benefit?
This trial targets individuals diagnosed with stress urinary incontinence, a condition affecting the ability to control urine leakage during physical activities like coughing, sneezing, or exercising. The interventions being studied aim to provide a non-invasive option that could alleviate symptoms and improve quality of life for patients worldwide.
Regulatory, clinical, and quality teams may also benefit from observing outcomes that could influence future market authorizations and device approvals for laser-based treatment modalities.
FAQ
- 1. What is the primary goal of this study?
This study primarily aims to evaluate the effectiveness of combining laser therapy with pelvic floor muscle training (PFMT) for treating stress urinary incontinence. - 2. When will recruitment start?
The study is listed as “Not yet recruiting” as of January 11, 2026. Interested parties should monitor updates on the official clinical trials page. - 3. Who is sponsoring this trial?
The trial is sponsored by Necmettin Erbakan University.
Conclusion
Necmettin Erbakan University’s upcoming clinical trial seeks to improve management strategies for stress urinary incontinence by combining innovative laser therapy and pelvic floor muscle training. Clinical teams, researchers, and regulatory professionals should monitor this study for insights that could influence future therapeutic protocols. Interested participants and stakeholders can consult the official link for more details.
Disclaimer
This content is intended for healthcare professionals and stakeholders involved in clinical and regulatory activities. It does not constitute legal or medical advice.
Full Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07319247?term=medical+device